StockNews.com initiated coverage on shares of Arcadia Biosciences (NASDAQ:RKDA – Free Report) in a research note released on Thursday. The brokerage issued a sell rating on the basic materials company’s stock.
Separately, HC Wainwright restated a buy rating and set a $6.00 price target on shares of Arcadia Biosciences in a report on Wednesday, August 21st.
Get Our Latest Analysis on Arcadia Biosciences
Arcadia Biosciences Stock Performance
Arcadia Biosciences (NASDAQ:RKDA – Get Free Report) last posted its quarterly earnings results on Tuesday, August 13th. The basic materials company reported $0.78 earnings per share for the quarter, missing the consensus estimate of $1.27 by ($0.49). Arcadia Biosciences had a negative return on equity of 57.51% and a negative net margin of 127.29%. The company had revenue of $1.31 million during the quarter, compared to analysts’ expectations of $0.95 million. During the same quarter in the previous year, the company earned ($2.64) EPS. Equities research analysts predict that Arcadia Biosciences will post -1.7 EPS for the current year.
About Arcadia Biosciences
Arcadia Biosciences, Inc produces and markets plant-based food and beverage products in the United States. The company develops crop improvements primarily in wheat to enhance farm economics by improving the performance of crops in the field, as well as their value as food ingredients. Its food, beverage, and body case products include GoodWheat, Zola coconut water, ProVault topical pain relief, and SoulSpring.
Recommended Stories
- Five stocks we like better than Arcadia Biosciences
- 3 Fintech Stocks With Good 2021 Prospects
- Can Celsius Stock Rebound? Analysts See 74% Upside Potential
- Options Trading – Understanding Strike Price
- Kroger Stock is a Win-Win for Buy-and-Hold Investors
- What Do S&P 500 Stocks Tell Investors About the Market?
- MarketBeat Week in Review – 9/9 – 9/13
Receive News & Ratings for Arcadia Biosciences Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Arcadia Biosciences and related companies with MarketBeat.com's FREE daily email newsletter.